 Dr Alan E. Walts joins Hemogenyx Pharmaceuticals team; renowned business leader brings industry experience in corporate and private venture capital, business development, RD and general management. LONDON, UK ACCESSWIRE July 26, 2021 Hemogenyx Pharmaceuticals plc LSE:HEMO, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces the appointment of Dr Alan E. 